USP1 and non-small cell lung carcinoma: USP1/UAF1 may act as an oncogene, because the inhibitors of USP1/UAF1 act synergistically with cisplatin in inhibiting cisplatin-resistant cell proliferation in NSCLC (Chen et al., 2011).